Citigroup’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$692M Buy
2,832,497
+629,905
+29% +$147M 0.3% 62
2025
Q4
$456M Buy
2,202,592
+610,817
+38% +$121M 0.2% 82
2025
Q3
$295M Sell
1,591,775
-925,181
-37% -$159M 0.13% 145
2025
Q2
$384M Sell
2,516,956
-92,935
-4% -$14.3M 0.19% 104
2025
Q1
$433M Buy
2,609,891
+953,406
+58% +$149M 0.22% 74
2024
Q4
$240M Buy
1,656,485
+158,679
+11% +$24.6M 0.14% 137
2024
Q3
$243M Sell
1,497,806
-864,920
-37% -$138M 0.14% 134
2024
Q2
$345M Sell
2,362,726
-110,184
-4% -$16.4M 0.22% 80
2024
Q1
$391M Buy
2,472,910
+336,583
+16% +$53.6M 0.26% 61
2023
Q4
$335M Sell
2,136,327
-39,394
-2% -$6.04M 0.24% 71
2023
Q3
$339M Buy
2,175,721
+188,728
+9% +$31.1M 0.25% 62
2023
Q2
$329M Sell
1,986,993
-316,405
-14% -$51.1M 0.22% 64
2023
Q1
$357M Buy
2,303,398
+148,962
+7% +$24.1M 0.25% 56
2022
Q4
$381M Sell
2,154,436
-64,956
-3% -$11.2M 0.3% 55
2022
Q3
$363M Buy
2,219,392
+198,774
+10% +$33.6M 0.26% 57
2022
Q2
$359M Sell
2,020,618
-11,697
-0.6% -$2.08M 0.27% 55
2022
Q1
$360M Sell
2,032,315
-501,440
-20% -$85.3M 0.22% 69
2021
Q4
$433M Sell
2,533,755
-277,149
-10% -$45.4M 0.23% 64
2021
Q3
$454M Sell
2,810,904
-91,621
-3% -$15.6M 0.27% 49
2021
Q2
$478M Sell
2,902,525
-578,758
-17% -$95.8M 0.29% 56
2021
Q1
$572M Buy
3,481,283
+345,999
+11% +$56M 0.37% 41
2020
Q4
$493M Buy
3,135,284
+120,757
+4% +$17.8M 0.29% 52
2020
Q3
$449M Buy
3,014,527
+516,382
+21% +$76.4M 0.29% 47
2020
Q2
$351M Buy
2,498,145
+421,914
+20% +$61.5M 0.27% 51
2020
Q1
$272M Sell
2,076,231
-495,138
-19% -$70.2M 0.25% 63
2019
Q4
$375M Buy
2,571,369
+578,981
+29% +$78.5M 0.27% 56
2019
Q3
$258M Sell
1,992,388
-195,694
-9% -$25.8M 0.2% 78
2019
Q2
$305M Buy
2,188,082
+1,010,457
+86% +$140M 0.25% 65
2019
Q1
$165M Sell
1,177,625
-397,896
-25% -$53.3M 0.16% 107
2018
Q4
$203M Buy
1,575,521
+263,612
+20% +$36.8M 0.21% 74
2018
Q3
$181M Buy
1,311,909
+123,506
+10% +$16.4M 0.16% 106
2018
Q2
$144M Sell
1,188,403
-18,229
-2% -$2.27M 0.13% 115
2018
Q1
$155M Sell
1,206,632
-34,788
-3% -$4.7M 0.13% 124
2017
Q4
$173M Buy
1,241,420
+23,328
+2% +$3.25M 0.14% 123
2017
Q3
$158M Buy
1,218,092
+242,178
+25% +$32.1M 0.13% 117
2017
Q2
$129M Sell
975,914
-1,016,225
-51% -$130M 0.12% 120
2017
Q1
$248M Buy
1,992,139
+278,878
+16% +$33.3M 0.22% 57
2016
Q4
$197M Buy
1,713,261
+559,567
+49% +$64.6M 0.18% 80
2016
Q3
$136M Sell
1,153,694
-60,963
-5% -$7.4M 0.13% 123
2016
Q2
$147M Sell
1,214,657
-222,711
-15% -$25.3M 0.15% 101
2016
Q1
$156M Sell
1,437,368
-103,589
-7% -$10.7M 0.17% 83
2015
Q4
$158M Sell
1,540,957
-165,191
-10% -$16.6M 0.16% 105
2015
Q3
$159M Sell
1,706,148
-913,214
-35% -$88.3M 0.15% 101
2015
Q2
$255M Sell
2,619,362
-106,759
-4% -$10.7M 0.23% 50
2015
Q1
$274M Buy
2,726,121
+200,620
+8% +$20.4M 0.27% 41
2014
Q4
$264M Buy
2,525,501
+225,202
+10% +$23.7M 0.24% 53
2014
Q3
$245M Sell
2,300,299
-950,266
-29% -$98.6M 0.21% 60
2014
Q2
$340M Buy
3,250,565
+1,031,991
+47% +$104M 0.33% 33
2014
Q1
$218M Sell
2,218,574
-1,071,983
-33% -$99.4M 0.22% 61
2013
Q4
$301M Sell
3,290,557
-173,900
-5% -$16M 0.27% 49
2013
Q3
$300M Buy
3,464,457
+1,715,131
+98% +$154M 0.28% 36
2013
Q2
$150M Buy
+1,749,326
New +$148M 0.15% 98

Other funds holding JNJ

Citigroup's JNJ Position: Q1 2026 in Review

Citigroup increased its Johnson & Johnson (JNJ) stake by 29% in Q1 2026, buying an estimated $147M and bringing the position to 2,832,497 shares worth $692M. The position accounts for 0.3% of the portfolio, ranked #62.

Citigroup first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Citigroup held 2,832,497 shares of Johnson & Johnson worth $692M as of Q1 2026.
  • Citigroup bought 629,905 Johnson & Johnson shares in Q1 2026, an estimated $147M.
  • Johnson & Johnson made up 0.3% of Citigroup's portfolio in Q1 2026, its #62 holding.
  • Citigroup first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.